Table 1. Patient characteristics of the... | American Society of Hematology

Table 1.

Patient characteristics of the training and validation cohorts

	Training		Validation		Total		P value
	(n = 113)		(n = 69)		(n = 182)
	No.	%	No.	%	No.	%
Study							<.001
BV-DHAP	58	51	0	0	58	32
BV-ICE	55	49	0	0	55	30
ICE-GVD	0	0	69	100	69	38
Female sex	61	54	32	46	93	51	.319
Median age, (range)	30 (13-65)		34 (18-66)		31 (13-66)		.175
Primary refractory	55	50	25	37	80	45	.062
Ann Arbor stage							.002
I	10	9	1	1	11	6	.042
II	46	41	43	62	89	49	.004
III	19	17	2	3	21	12	.004
IV	38	34	23	33	61	34	.970
Extranodal disease	44	39	25	36	69	38	.715
B symptoms	28	25	7	10	35	20	.011

	Training		Validation		Total		P value
	(n = 113)		(n = 69)		(n = 182)
	No.	%	No.	%	No.	%
Study							<.001
BV-DHAP	58	51	0	0	58	32
BV-ICE	55	49	0	0	55	30
ICE-GVD	0	0	69	100	69	38
Female sex	61	54	32	46	93	51	.319
Median age, (range)	30 (13-65)		34 (18-66)		31 (13-66)		.175
Primary refractory	55	50	25	37	80	45	.062
Ann Arbor stage							.002
I	10	9	1	1	11	6	.042
II	46	41	43	62	89	49	.004
III	19	17	2	3	21	12	.004
IV	38	34	23	33	61	34	.970
Extranodal disease	44	39	25	36	69	38	.715
B symptoms	28	25	7	10	35	20	.011